Skip Surgery: A Single Shot Tackles Knee Pain for a Year

If you’ve been limping through life with knee pain that won’t quit, there’s fresh hope on the horizon—and it doesn’t involve going under the knife.

A minimally invasive procedure called genicular artery embolization (GAE) is reshaping how doctors treat osteoarthritis-related knee pain. The approach is elegantly simple: abnormal blood vessels in arthritic knees drive inflammation and pain, so doctors use a thin catheter to block those vessels with tiny, rapidly dissolving gelatin particles. One injection. No surgery. Real relief for at least 12 months.

The evidence is compelling. Dr. Florian Fleckenstein led a major trial in Berlin that tracked 194 patients—114 women and 80 men averaging 69 years old—all struggling with knee pain that hadn’t improved after at least three months of standard treatments like physical therapy, anti-inflammatory drugs, and intra-articular injections. Between July and November 2024, all underwent GAE procedures. About one in four patients needed two procedures for bilateral knee osteoarthritis. The results, published in the journal Radiology, were striking: 80% of participants achieved clinically meaningful pain improvements by the 12-month mark, with significant gains in function, mobility, and quality of life. Only 6.7% experienced mild, self-limited reactions. No moderate or severe adverse events.

“For the right patient, it can mean lasting relief from a single, minimally invasive procedure—a meaningful new option between injections and joint replacement,”Fleckenstein said. What makes this particularly significant is that GAE may be the first procedure that doesn’t just ease symptoms but actually alters the disease’s progression, potentially slowing how fast osteoarthritis advances. By normalizing the abnormal vessel structure around the knee, the procedure also resets the nerve environment—addressing both inflammation and pain at their source.

Knee osteoarthritis affects more than 365 million adults worldwide and ranks among the leading causes of disability globally. For many patients, joint replacement isn’t realistic due to medical complications or personal preference, leaving them trapped in a treatment gap. GAE offers something genuinely new: a middle path that’s safer than surgery, more durable than injections, and backed by real-world data from patients exactly like those sitting in doctors’offices today.

The largest body of evidence yet for this technique comes from this single study, giving clinicians real confidence in both its safety and effectiveness. If you’ve been told knee pain is just something you’ll have to live with, it might be time to ask your doctor about GAE.